|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
1995-8-16
|
|
pubmed:abstractText |
Antioxidant and antiplatelet drugs might help prevent the progression of atherosclerosis or its thrombotic consequences as adjuncts to specific treatment of cardiovascular risk factors.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
1350-6277
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
2
|
|
pubmed:owner |
NLM
|
|
pubmed:pagination |
137-42
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:7606650-Aged,
pubmed-meshheading:7606650-Arteriosclerosis,
pubmed-meshheading:7606650-Aspirin,
pubmed-meshheading:7606650-Cardiovascular Diseases,
pubmed-meshheading:7606650-Clinical Protocols,
pubmed-meshheading:7606650-Diabetes Complications,
pubmed-meshheading:7606650-Disease Progression,
pubmed-meshheading:7606650-Epidemiologic Methods,
pubmed-meshheading:7606650-Family Practice,
pubmed-meshheading:7606650-Feasibility Studies,
pubmed-meshheading:7606650-Female,
pubmed-meshheading:7606650-Humans,
pubmed-meshheading:7606650-Hypercholesterolemia,
pubmed-meshheading:7606650-Hypertension,
pubmed-meshheading:7606650-Male,
pubmed-meshheading:7606650-Middle Aged,
pubmed-meshheading:7606650-Myocardial Infarction,
pubmed-meshheading:7606650-Obesity,
pubmed-meshheading:7606650-Patient Selection,
pubmed-meshheading:7606650-Primary Prevention,
pubmed-meshheading:7606650-Risk Factors,
pubmed-meshheading:7606650-Thrombosis,
pubmed-meshheading:7606650-Vitamin E
|
|
pubmed:year |
1995
|
|
pubmed:articleTitle |
Epidemiological feasibility of cardiovascular primary prevention in general practice: a trial of vitamin E and aspirin. Collaborative group of the Primary Prevention Project.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
